Throughout the ages, people have been fascinated as to how mortals could achieve immortality, just like the gods. They have been searching for magical spells, elixirs and even a fountain of youth, in order to achieve the fantasy of living forever. For the first time in the history of mankind, with the aid of science and modern technology, the key to immortality can be introduced in a few years. Scientists have been stating that aging is a normal process, and it will cause our cells to degenerate over time, leading to death. However, a new theory came out which states that the aging process is actually a continuation of growth, and a substance called rapamycin can treat aging, given in right doses at the correct schedule. Aside from the potential of being an anti-aging drug, rapamycin can also treat different diseases by boosting the immune system. This type of drug is considered as a work of fiction for some, but this is actually a real possibility, thanks to Dr. Mikhail Blagosklonny’s effort. View Mikhail’s profile in LinkedIn
Dr. Mikhail Blagosklonny is a graduate of First Pavlov State Medical University of St. Petersburg, where he got his MD and Ph.D. His fascination with the anti-aging drug came about when he was teaching at the Roswell Park Cancer Institute as a professor of oncology. His expertise back then was all about the different types of cancer and the ways on how to treat them. He managed to discover the potential of the rapamycin drug, and decided to kick off a research study on the benefits of the substance. What he found out during the study was that rapamycin has two centric models that would stop the aging process, namely TOR and MTOR. These two are signals coming from the rapamycin that is responsible for stopping the degeneration of the cells, and creating new ones, as well as making the immunity stronger to fend off diseases. This is considered to be a milestone in his quest for immortality, and he never stopped from there. With his passion to discover the anti-aging drug, he looked deeper into the centric models to find out if they are obtainable somewhere else, aside from the rapamycin substance. He soon discovered that the TOR centric model can be obtained from three different sources – genetics, cellular senescence, and diseases.
Dr. Mikhail Blagosklonny found out that TOR centric models are found in some genes, and it can be passed along an offspring, that is why he considered genetics as a possible source. The right amount of rapamycin given to a degenerating cell can transform it back into a fresh new cell, and it will create a TOR centric model in the process. This second source is from cellular senescence, and the amount of TOR centric model that it produces is relatively moderate. The final source of the TOR centric model would be from diseases, like Parkinson’s disease, Alzheimer’s disease, cancers and tumors. For MTOR models, Dr. Mikhail Blagosklonny has already proven their existence but he could not find another source.
The scientists who reviewed his study rejected it years ago, but everything is now changing as the scientific community is slowly accepting the possibility of immortality through the model that Dr. Mikhail Blagosklonny has introduced. In fact, some pharmaceutical companies are already producing their own anti-aging drug based on the research of Dr. Mikhail Blagosklonny. We are indeed living in the future, with endless possibilities coming on our way.